Literature DB >> 3802116

Phase II trial of vindesine in malignant pleural mesothelioma.

C Boutin, M Irisson, J C Guérin, E Roegel, B Paramelle, C Brambilla, L Jeannin, G Dabouis, H Le Caer, J R Viallat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3802116

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

Review 1.  Chemotherapy in malignant mesothelioma: a review.

Authors:  A Krarup-Hansen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 2.  Chemotherapy for malignant pleural mesothelioma: past results and recent developments.

Authors:  S Tomek; S Emri; K Krejcy; C Manegold
Journal:  Br J Cancer       Date:  2003-01-27       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.